Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811531) titled 'A Clinical Investigation of a Topical Moisturizer on Skin Barrier Function in Adults With Sensitive Skin' on Sept. 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Good Molecules, LLC
Condition:
Sensitive Skin
Intervention:
Other: White petrolatum
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: September 14, 2026
Target Sample Size: 24
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/stu...